(Q39897395)

English

The treatment with N-acetylcysteine of Raynaud's phenomenon and ischemic ulcers therapy in sclerodermic patients: a prospective observational study of 50 patients.

scientific article published on 20 August 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19690939%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

The treatment with N-acetylcysteine of Raynaud's phenomenon and ischemic ulcers therapy in sclerodermic patients: a prospective observational study of 50 patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19690939%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

0 references

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19690939%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Federica Borghese

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19690939%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Simonetta Pisarri

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19690939%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Felice Salsano

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19690939%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

20 August 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19690939%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Clinical Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19690939%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19690939%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19690939%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1379-1384

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19690939%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Total recovery of left ventricular function after acute myocardial infarction: comprehensive therapy with streptokinase, N-acetylcysteine and percutaneous transluminal coronary angioplasty

1 reference

https://pubmed.ncbi.nlm.nih.gov/19690939

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

N-acetylcysteine in the prevention of radiocontrast-induced nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19690939

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19690939

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of N-acetylcysteine on endothelial dysfunction in dialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19690939

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19690939

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19690939

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of thermal infrared and laser doppler imaging in the assessment of cutaneous tissue perfusion in scleroderma patients and healthy controls

1 reference

https://pubmed.ncbi.nlm.nih.gov/19690939

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

1 reference

https://pubmed.ncbi.nlm.nih.gov/19690939

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular complications of scleroderma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19690939

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathogenesis of Raynaud's phenomenon.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19690939

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19690939

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19690939

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19690939

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose acetylcysteine in idiopathic pulmonary fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19690939

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19690939

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Raynaud's phenomenon

1 reference

https://pubmed.ncbi.nlm.nih.gov/19690939

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic treatment with N-acetyl-cystein delays cellular senescence in endothelial cells isolated from a subgroup of atherosclerotic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19690939

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous N-acetylcysteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: a pilot study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19690939

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral N-acetylcysteine attenuates pulmonary emphysema and alveolar septal cell apoptosis in smoking-induced COPD in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/19690939

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19690939

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current drug therapy for scleroderma and secondary Raynaud's phenomenon: evidence-based review

1 reference

https://pubmed.ncbi.nlm.nih.gov/19690939

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significant changes of peripheral perfusion and plasma adrenomedullin levels in N-acetylcysteine long term treatment of patients with sclerodermic Raynauds phenomenon

1 reference

https://pubmed.ncbi.nlm.nih.gov/19690939

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression

1 reference

https://pubmed.ncbi.nlm.nih.gov/19690939

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathogenesis of systemic sclerosis: A vascular hypothesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19690939

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

N-Acetylcysteine improves renal dysfunction, ameliorates kidney damage and decreases blood pressure in salt-sensitive hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/19690939

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39897395&oldid=2092302519"